The global External Neuromodulation market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Medtronic, Inc. (U.S.)
Boston Scientific Corporation (U.S.)
St. Jude Medical, Inc. (U.S.)
Synapse Biomedical, Inc. (U.S.)
Nevro Corporation (U.S.)
Neurosigma, Inc. (U.S.)
Neuropace, Inc. (U.S.)
Neuronetics, Inc. (U.S.)
Cyberonics, Inc. (U.S.)
BioControl Medical (Israel)
By Types:
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
By Applications:
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global External Neuromodulation Market Size Analysis from 2023 to 2028
1.5.1 Global External Neuromodulation Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global External Neuromodulation Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global External Neuromodulation Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: External Neuromodulation Industry Impact
Chapter 2 Global External Neuromodulation Competition by Types, Applications, and Top Regions and Countries
2.1 Global External Neuromodulation (Volume and Value) by Type
2.1.1 Global External Neuromodulation Consumption and Market Share by Type (2017-2022)
2.1.2 Global External Neuromodulation Revenue and Market Share by Type (2017-2022)
2.2 Global External Neuromodulation (Volume and Value) by Application
2.2.1 Global External Neuromodulation Consumption and Market Share by Application (2017-2022)
2.2.2 Global External Neuromodulation Revenue and Market Share by Application (2017-2022)
2.3 Global External Neuromodulation (Volume and Value) by Regions
2.3.1 Global External Neuromodulation Consumption and Market Share by Regions (2017-2022)
2.3.2 Global External Neuromodulation Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global External Neuromodulation Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global External Neuromodulation Consumption by Regions (2017-2022)
4.2 North America External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.4 Europe External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.8 Africa External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
4.10 South America External Neuromodulation Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America External Neuromodulation Market Analysis
5.1 North America External Neuromodulation Consumption and Value Analysis
5.1.1 North America External Neuromodulation Market Under COVID-19
5.2 North America External Neuromodulation Consumption Volume by Types
5.3 North America External Neuromodulation Consumption Structure by Application
5.4 North America External Neuromodulation Consumption by Top Countries
5.4.1 United States External Neuromodulation Consumption Volume from 2017 to 2022
5.4.2 Canada External Neuromodulation Consumption Volume from 2017 to 2022
5.4.3 Mexico External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 6 East Asia External Neuromodulation Market Analysis
6.1 East Asia External Neuromodulation Consumption and Value Analysis
6.1.1 East Asia External Neuromodulation Market Under COVID-19
6.2 East Asia External Neuromodulation Consumption Volume by Types
6.3 East Asia External Neuromodulation Consumption Structure by Application
6.4 East Asia External Neuromodulation Consumption by Top Countries
6.4.1 China External Neuromodulation Consumption Volume from 2017 to 2022
6.4.2 Japan External Neuromodulation Consumption Volume from 2017 to 2022
6.4.3 South Korea External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 7 Europe External Neuromodulation Market Analysis
7.1 Europe External Neuromodulation Consumption and Value Analysis
7.1.1 Europe External Neuromodulation Market Under COVID-19
7.2 Europe External Neuromodulation Consumption Volume by Types
7.3 Europe External Neuromodulation Consumption Structure by Application
7.4 Europe External Neuromodulation Consumption by Top Countries
7.4.1 Germany External Neuromodulation Consumption Volume from 2017 to 2022
7.4.2 UK External Neuromodulation Consumption Volume from 2017 to 2022
7.4.3 France External Neuromodulation Consumption Volume from 2017 to 2022
7.4.4 Italy External Neuromodulation Consumption Volume from 2017 to 2022
7.4.5 Russia External Neuromodulation Consumption Volume from 2017 to 2022
7.4.6 Spain External Neuromodulation Consumption Volume from 2017 to 2022
7.4.7 Netherlands External Neuromodulation Consumption Volume from 2017 to 2022
7.4.8 Switzerland External Neuromodulation Consumption Volume from 2017 to 2022
7.4.9 Poland External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 8 South Asia External Neuromodulation Market Analysis
8.1 South Asia External Neuromodulation Consumption and Value Analysis
8.1.1 South Asia External Neuromodulation Market Under COVID-19
8.2 South Asia External Neuromodulation Consumption Volume by Types
8.3 South Asia External Neuromodulation Consumption Structure by Application
8.4 South Asia External Neuromodulation Consumption by Top Countries
8.4.1 India External Neuromodulation Consumption Volume from 2017 to 2022
8.4.2 Pakistan External Neuromodulation Consumption Volume from 2017 to 2022
8.4.3 Bangladesh External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia External Neuromodulation Market Analysis
9.1 Southeast Asia External Neuromodulation Consumption and Value Analysis
9.1.1 Southeast Asia External Neuromodulation Market Under COVID-19
9.2 Southeast Asia External Neuromodulation Consumption Volume by Types
9.3 Southeast Asia External Neuromodulation Consumption Structure by Application
9.4 Southeast Asia External Neuromodulation Consumption by Top Countries
9.4.1 Indonesia External Neuromodulation Consumption Volume from 2017 to 2022
9.4.2 Thailand External Neuromodulation Consumption Volume from 2017 to 2022
9.4.3 Singapore External Neuromodulation Consumption Volume from 2017 to 2022
9.4.4 Malaysia External Neuromodulation Consumption Volume from 2017 to 2022
9.4.5 Philippines External Neuromodulation Consumption Volume from 2017 to 2022
9.4.6 Vietnam External Neuromodulation Consumption Volume from 2017 to 2022
9.4.7 Myanmar External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 10 Middle East External Neuromodulation Market Analysis
10.1 Middle East External Neuromodulation Consumption and Value Analysis
10.1.1 Middle East External Neuromodulation Market Under COVID-19
10.2 Middle East External Neuromodulation Consumption Volume by Types
10.3 Middle East External Neuromodulation Consumption Structure by Application
10.4 Middle East External Neuromodulation Consumption by Top Countries
10.4.1 Turkey External Neuromodulation Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia External Neuromodulation Consumption Volume from 2017 to 2022
10.4.3 Iran External Neuromodulation Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates External Neuromodulation Consumption Volume from 2017 to 2022
10.4.5 Israel External Neuromodulation Consumption Volume from 2017 to 2022
10.4.6 Iraq External Neuromodulation Consumption Volume from 2017 to 2022
10.4.7 Qatar External Neuromodulation Consumption Volume from 2017 to 2022
10.4.8 Kuwait External Neuromodulation Consumption Volume from 2017 to 2022
10.4.9 Oman External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 11 Africa External Neuromodulation Market Analysis
11.1 Africa External Neuromodulation Consumption and Value Analysis
11.1.1 Africa External Neuromodulation Market Under COVID-19
11.2 Africa External Neuromodulation Consumption Volume by Types
11.3 Africa External Neuromodulation Consumption Structure by Application
11.4 Africa External Neuromodulation Consumption by Top Countries
11.4.1 Nigeria External Neuromodulation Consumption Volume from 2017 to 2022
11.4.2 South Africa External Neuromodulation Consumption Volume from 2017 to 2022
11.4.3 Egypt External Neuromodulation Consumption Volume from 2017 to 2022
11.4.4 Algeria External Neuromodulation Consumption Volume from 2017 to 2022
11.4.5 Morocco External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 12 Oceania External Neuromodulation Market Analysis
12.1 Oceania External Neuromodulation Consumption and Value Analysis
12.2 Oceania External Neuromodulation Consumption Volume by Types
12.3 Oceania External Neuromodulation Consumption Structure by Application
12.4 Oceania External Neuromodulation Consumption by Top Countries
12.4.1 Australia External Neuromodulation Consumption Volume from 2017 to 2022
12.4.2 New Zealand External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 13 South America External Neuromodulation Market Analysis
13.1 South America External Neuromodulation Consumption and Value Analysis
13.1.1 South America External Neuromodulation Market Under COVID-19
13.2 South America External Neuromodulation Consumption Volume by Types
13.3 South America External Neuromodulation Consumption Structure by Application
13.4 South America External Neuromodulation Consumption Volume by Major Countries
13.4.1 Brazil External Neuromodulation Consumption Volume from 2017 to 2022
13.4.2 Argentina External Neuromodulation Consumption Volume from 2017 to 2022
13.4.3 Columbia External Neuromodulation Consumption Volume from 2017 to 2022
13.4.4 Chile External Neuromodulation Consumption Volume from 2017 to 2022
13.4.5 Venezuela External Neuromodulation Consumption Volume from 2017 to 2022
13.4.6 Peru External Neuromodulation Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico External Neuromodulation Consumption Volume from 2017 to 2022
13.4.8 Ecuador External Neuromodulation Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in External Neuromodulation Business
14.1 Medtronic, Inc. (U.S.)
14.1.1 Medtronic, Inc. (U.S.) Company Profile
14.1.2 Medtronic, Inc. (U.S.) External Neuromodulation Product Specification
14.1.3 Medtronic, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Boston Scientific Corporation (U.S.)
14.2.1 Boston Scientific Corporation (U.S.) Company Profile
14.2.2 Boston Scientific Corporation (U.S.) External Neuromodulation Product Specification
14.2.3 Boston Scientific Corporation (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 St. Jude Medical, Inc. (U.S.)
14.3.1 St. Jude Medical, Inc. (U.S.) Company Profile
14.3.2 St. Jude Medical, Inc. (U.S.) External Neuromodulation Product Specification
14.3.3 St. Jude Medical, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Synapse Biomedical, Inc. (U.S.)
14.4.1 Synapse Biomedical, Inc. (U.S.) Company Profile
14.4.2 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Product Specification
14.4.3 Synapse Biomedical, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Nevro Corporation (U.S.)
14.5.1 Nevro Corporation (U.S.) Company Profile
14.5.2 Nevro Corporation (U.S.) External Neuromodulation Product Specification
14.5.3 Nevro Corporation (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Neurosigma, Inc. (U.S.)
14.6.1 Neurosigma, Inc. (U.S.) Company Profile
14.6.2 Neurosigma, Inc. (U.S.) External Neuromodulation Product Specification
14.6.3 Neurosigma, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Neuropace, Inc. (U.S.)
14.7.1 Neuropace, Inc. (U.S.) Company Profile
14.7.2 Neuropace, Inc. (U.S.) External Neuromodulation Product Specification
14.7.3 Neuropace, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Neuronetics, Inc. (U.S.)
14.8.1 Neuronetics, Inc. (U.S.) Company Profile
14.8.2 Neuronetics, Inc. (U.S.) External Neuromodulation Product Specification
14.8.3 Neuronetics, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Cyberonics, Inc. (U.S.)
14.9.1 Cyberonics, Inc. (U.S.) Company Profile
14.9.2 Cyberonics, Inc. (U.S.) External Neuromodulation Product Specification
14.9.3 Cyberonics, Inc. (U.S.) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 BioControl Medical (Israel)
14.10.1 BioControl Medical (Israel) Company Profile
14.10.2 BioControl Medical (Israel) External Neuromodulation Product Specification
14.10.3 BioControl Medical (Israel) External Neuromodulation Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global External Neuromodulation Market Forecast (2023-2028)
15.1 Global External Neuromodulation Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global External Neuromodulation Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global External Neuromodulation Value and Growth Rate Forecast (2023-2028)
15.2 Global External Neuromodulation Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global External Neuromodulation Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global External Neuromodulation Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America External Neuromodulation Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global External Neuromodulation Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global External Neuromodulation Consumption Forecast by Type (2023-2028)
15.3.2 Global External Neuromodulation Revenue Forecast by Type (2023-2028)
15.3.3 Global External Neuromodulation Price Forecast by Type (2023-2028)
15.4 Global External Neuromodulation Consumption Volume Forecast by Application (2023-2028)
15.5 External Neuromodulation Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Education Industry Security Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
The Sustainable Energy Solutions for Education Industry Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, compet...
The Intelligent Energy Management System (EMS) for Industry Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, co...
The Cold Chain Industry Digital Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Industry Supervision Big Data Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Europe Vascular Closure Devices Market is poised for significant growth from 2024 to 2034, driven by advancements in minimally invasive procedures, increasing procedural volumes, and a growing preference for vascular closure solutions that enhance patient outcomes. T...
Market Overview
The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vasc...
Market Overview
The Global Vascular Closure Devices Market is projected to grow substantially from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures and the rising demand for fast, efficient vascular closure solutions. In 2024, the market is v...
The Industry Standards Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...